About: Effects of essential oils on symptoms and course (duration and severity) of viral respiratory infections in humans: A rapid review

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effects of essential oils on symptoms and course (duration and severity) of viral respiratory infections in humans: A rapid review Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Effects of essential oils on symptoms and course (duration and severity) of viral respiratory infections in humans: A rapid review
Creator	Steel, Amie Agnew, Tamara Benett, Kathleen Bowles, E Cooke, Carolyn Hausser, Tina Prall, Sebastian
Source	Elsevier; Medline; PMC
abstract	Oral doses of certain essential oils may reduce symptoms of acute respiratory infections of viral origin. It is likely that the commercially available essential oil capsules Myrtol® (a mixture of essential oils of eucalyptus Eucalyptus globulus, sweet orange Citrus sinensis, myrtle Myrtus communis and lemon Citrus limonum) and Tavipec® (spike lavender Lavandula latifolia) could also provide mild to moderate symptom relief in patients with viral respiratory diseases. Myrtol® may also improve the course (duration and severity) of acute bronchitis of viral origin, in humans. Both products were well tolerated, with most of the mild to moderate side-effects affecting the gastrointestinal tract. This review found no research evidence describing the clinical effect of inhalation of essential oils for acute respiratory viral infections.
has issue date	2020-08-03(xsd:dateTime)
bibo:doi	10.1016/j.aimed.2020.07.005
bibo:pmid	32837899
has license	no-cc
sha1sum (hex)	b46067e2b2e88e3c38d78620af0b8f1854a7b245
schema:url	https://doi.org/10.1016/j.aimed.2020.07.005
resource representing a document's title	Effects of essential oils on symptoms and course (duration and severity) of viral respiratory infections in humans: A rapid review
has PubMed Central identifier	PMC7398051
has PubMed identifier	32837899
schema:publication	Adv Integr Med
resource representing a document's body	covid:b46067e2b2e88e3c38d78620af0b8f1854a7b245#body_text
is schema:about of	named entity 'Myrtus communis' named entity 'lavender' named entity 'duration' named entity 'essential oils' named entity 'Brief' named entity 'ACUTE BRONCHITIS' named entity 'respiratory' named entity 'side-effects' named entity 'Myrtus communis' named entity 'Lavandula latifolia' named entity 'essential oils' named entity 'essential oils' named entity 'respiratory infections' named entity 'respiratory infections' named entity 'essential oils' named entity 'acute respiratory infections' named entity 'Citrus sinensis' named entity 'statistically significant results' named entity 'subjective symptom' named entity 'upper respiratory tract infection' named entity 'statistically significantly' named entity 'essential oil' named entity 'symptom' named entity 'Myrtus communis' named entity 'randomised trials' named entity 'double-blind, placebo-controlled' named entity 'coronavirus' named entity 'symptom' named entity 'clinical signs' named entity 'upper respiratory tract infections' named entity 'bacterial infection' named entity 'reduce symptoms' named entity 'acute bronchitis' named entity 'Daltons' named entity 'acute sinusitis' named entity 'Placebo' named entity 'randomized controlled trials' named entity 'phenylpropanoid' named entity 'respiratory infection' named entity 'placebo' named entity 'reduce symptoms' named entity 'in-silico' named entity 'Eucalyptus globulus' named entity 'upper respiratory tract infections' named entity 'symptom' named entity 'placebo' named entity '10.5' named entity 'enteric coated' named entity 'placebo' named entity 'sweet orange' named entity 'Eucalyptus globulus' named entity 'essential oils' named entity 'clinical trial' named entity 'pharyngotonsillitis' named entity 'COPD' named entity 'quality of life' named entity 'Adverse events' named entity 'essential oils' named entity 'mode of action' named entity 'statistically significant' named entity 'placebo' named entity 'anti-bacterial' named entity 'reduce symptoms' named entity 'EJB' named entity 'essential oil' named entity 'clinical trial' named entity 'acute sinusitis' named entity 'capsules' named entity 'orally-administered' named entity 'acute bronchitis' named entity 'gastrointestinal' named entity 'clinical trials' named entity 'clinical trials' named entity 'clinical setting' named entity 'symptom'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software